Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
28,208
Sort by:
Leber congenital amaurosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Leber congenital amaurosis - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+...
September 2021
60 pages
Lung transplant rejection - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Lung transplant rejection - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pip...
September 2021
60 pages
Meibomian Gland Dysfunction - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Meibomian Gland Dysfunction – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 8...
September 2021
60 pages
Myositis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Myositis - Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline...
September 2021
60 pages
Nephrotic syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Nephrotic syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...
September 2021
60 pages
Niemann-Pick Type C Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Niemann-Pick Type C Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 13+ companies and...
September 2021
60 pages
Peripheral nerve injuries - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Peripheral nerve injuries - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ p...
September 2021
60 pages
Proliferative vitreoretinopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Proliferative vitreoretinopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
September 2021
60 pages
Rabies infection - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Rabies infection – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipelin...
September 2021
60 pages
Ragweed pollen hypersensitivity - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Ragweed pollen hypersensitivity - Pipeline Insight, 2021,” report provides comprehensive insights about 2+ companies and...
September 2021
60 pages
Schizoaffective Disorder - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Schizoaffective Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipe...
September 2021
60 pages
Sturge-Weber Syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Sturge-Weber Syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipelin...
September 2021
60 pages
Toll-like-receptor-agonists - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 3-4 working days DelveInsight’s, “Toll-like-receptor-agonists - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies...
September 2021
100 pages
Ulcerative proctitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Ulcerative proctitis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
September 2021
60 pages
Estrogen Receptor Beta - Drugs In Development, 2021
US$ 3,500.00
Estrogen Receptor Beta - Drugs In Development, 2021 SUMMARY According to the recently published report 'Estrogen Receptor Beta - Drugs In Development, 2021'; Estrogen Receptor Beta (ER Beta or Nuclear...
August 2021
77 pages
Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021
US$ 3,500.00
Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Gamma Secretase - Drugs In Development, 2021'; Gamma Secretase (EC 3.4.23.) pipeline Targe...
August 2021
87 pages
Retinoic Acid Receptor Alpha - Drugs In Development, 2021
US$ 3,500.00
Retinoic Acid Receptor Alpha - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) pipeline Target constitutes...
August 2021
76 pages
Retinoic Acid Receptor Gamma - Drugs In Development, 2021
US$ 3,500.00
Retinoic Acid Receptor Gamma - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Retinoic acid receptor ga...
August 2021
88 pages
Asthma (Respiratory) - Drugs In Development, 2021
US$ 2,500.00
Asthma (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Drugs In Development, 2021, provides an overview...
August 2021
931 pages
Bone Metastasis (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Bone Metastasis (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bone Metastasis - Drugs In Development, 2021, provid...
August 2021
106 pages
Bronchiectasis (Respiratory) - Drugs In Development, 2021
US$ 2,000.00
Bronchiectasis (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2021, provi...
August 2021
123 pages
Cataract (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Cataract (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cataract - Drugs In Development, 2021, provides an ove...
August 2021
46 pages
Gastric Cancer (Oncology) - Drugs In Development, 2021
US$ 2,500.00
Gastric Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Drugs In Development, 2021, provides...
August 2021
3373 pages
Hairy Cell Leukemia (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Hairy Cell Leukemia (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hairy Cell Leukemia - Drugs In Development, 2021...
August 2021
194 pages
Head And Neck Cancer (Oncology) - Drugs In Development, 2021
US$ 2,500.00
Head And Neck Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Drugs In Development, 20...
August 2021
4327 pages
Keratitis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Keratitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keratitis - Drugs In Development, 2021, provides an o...
August 2021
105 pages
Optic Neuritis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Optic Neuritis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuritis - Drugs In Development, 2021, pro...
August 2021
57 pages
